c-Met, a tyrosine kinase receptor for hepatocyte growth factor (HGF), is associated with metastasis and tumour invasion, decreased survival, and was recently investigated as a marker for CSCs in HNSCC [54, 95, 96]. The gene discussed is MET; the disease is neoplasm.